{"schema_version":"secwatch.filing_event.v1","accession":"0001161697-24-000440","form_type":"8-K","ticker":"KRMD","cik":"0000704440","company_name":"KORU Medical Systems, Inc.","filed_at":"2024-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.835103+00:00","generated_at":"2026-05-30T01:22:45.170266+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"KORU Medical Q3 revenue $8.2M (+17% YoY); raises FY 2024 guidance","bullets":["Q3 net revenue $8.2M, up 17% YoY; gross margin 63.4%, up 140 bps from 62.0%.","Core revenue $7.6M (+11% YoY); novel therapies $0.6M (+276% YoY).","Net loss $1.6M ($0.03 diluted EPS); adjusted EBITDA loss $0.4M.","Raises FY 2024 revenue guidance to $32.75-33.25M (15-17% growth) from $32.0-32.5M.","Raises FY 2024 gross margin guidance to 62-63%; year-end cash guidance >$8.8M."],"urls":{"canonical":"https://secwatch.observer/filing/0001161697-24-000440","json":"https://secwatch.observer/filing/0001161697-24-000440.json","markdown":"https://secwatch.observer/filing/0001161697-24-000440.md","text":"https://secwatch.observer/filing/0001161697-24-000440.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/704440/000116169724000440/0001161697-24-000440-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/704440/000116169724000440/form_8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T01:22:45.170266+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}